FilingReader Intelligence
WuXi Biologics increases issued shares through option exercises, buybacks
July 9, 2025 at 05:00 AM UTC•By FilingReader AI
WuXi Biologics (Cayman) Inc. announced a change in its issued share capital as of July 8, 2025. The company issued 176,320 new ordinary shares through the exercise of share options granted under its Pre-IPO Share Option Scheme and share scheme. These shares were issued at prices ranging from HKD 1.29 to HKD 3.41 per share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when WuXi Biologics (Cayman) Inc publishes news
Free account required • Unsubscribe anytime